Personalised therapy for lung cancer
21 Dec 2016
Personalised therapy for lung cancer
Interdisciplinarity in the genetics of cancer
Current and future directions of immunotherapy research
Managing metastatic gastric cancer
Combination immunotherapy for lung cancer
Biomarker driven clinical trials
Decoding breast cancer predisposition genes
Matched mutations in the progression of metastatic breast cancer
Whole exome and transcriptome sequencing of resistant ER positive metastatic breast cancer
Pacritinib versus best available therapy for low platelet Myelofibrosis
ASH 2016 highlights: breaking new ground in haematology
IKZF1 mutations associated with paediatric ALL